Mizuho Securities USA’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.5M Sell
75,005
-15,333
-17% -$2.15M 0.25% 79
2025
Q4
$11.4M Sell
90,338
-34
-0% -$4.13K 0.19% 84
2025
Q3
$10.2M Buy
90,372
+4,399
+5% +$500K 0.21% 90
2025
Q2
$9.53M Sell
85,973
-13,815
-14% -$1.47M 0.2% 90
2025
Q1
$11.2M Sell
99,788
-18,330
-16% -$1.89M 0.24% 79
2024
Q4
$10.9M Buy
118,118
+37,387
+46% +$3.37M 0.2% 93
2024
Q3
$6.77M Sell
80,731
-15,329
-16% -$1.17M 0.15% 123
2024
Q2
$6.59M Buy
+96,060
New +$6.41M 0.15% 128
2017
Q2
Sell
-71,200
Closed -$4.93M 183
2017
Q1
$4.93M Buy
+71,200
New +$5.01M 0.27% 21
2016
Q4
Sell
-50,000
Closed -$3.96M 209
2016
Q3
$3.96M Buy
+50,000
New +$4.06M 0.33% 50
2016
Q2
Sell
-30,000
Closed -$2.76M 205
2016
Q1
$2.76M Buy
+30,000
New +$2.71M 0.62% 22
2015
Q3
Sell
-4,351
Closed -$509K 151
2015
Q2
$509K Sell
4,351
-38,478
-90% -$4.2M 0.06% 123
2015
Q1
$4.2M Sell
42,829
-22,230
-34% -$2.26M 0.54% 43
2014
Q4
$6.13M Buy
65,059
+38,729
+147% +$4.01M 0.6% 39
2014
Q3
$2.8M Buy
+26,330
New +$2.58M 0.33% 41
2014
Q1
Sell
-185,136
Closed -$13.9M 52
2013
Q4
$13.9M Buy
185,136
+53,107
+40% +$3.7M 1.15% 18
2013
Q3
$8.3M Sell
132,029
-22,382
-14% -$1.34M 0.53% 33
2013
Q2
$7.91M Buy
+154,411
New +$8.05M 0.39% 32

Other funds holding GILD

Mizuho Securities USA's GILD Position: Q1 2026 in Review

Mizuho Securities USA reduced its Gilead Sciences (GILD) stake by 17% in Q1 2026, selling an estimated $2.15M and leaving 75,005 shares worth $10.5M. The position accounts for 0.25% of the portfolio, ranked #79.

Mizuho Securities USA first reported a position in GILD in Q2 2013 and has held it in 18 quarters since. The position peaked at $13.9M in Q4 2013. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Mizuho Securities USA held 75,005 shares of Gilead Sciences worth $10.5M as of Q1 2026.
  • Mizuho Securities USA sold 15,333 Gilead Sciences shares in Q1 2026, an estimated $2.15M.
  • Gilead Sciences made up 0.25% of Mizuho Securities USA's portfolio in Q1 2026, its #79 holding.
  • Mizuho Securities USA first reported a position in Gilead Sciences in Q2 2013 and has held it in 18 quarters since.
  • Mizuho Securities USA's Gilead Sciences position peaked at $13.9M in Q4 2013.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Mizuho Securities USA's 13F filing for Q1 2026, filed 11 May 2026.